Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Gynecologic oncology (Print)

Results: 1-25/365

Authors: KELLY DG STANHOPE CR
Citation: Dg. Kelly et Cr. Stanhope, POSTOPERATIVE ENTERAL FEEDING - MYTH OR FACT, Gynecologic oncology, 67(3), 1997, pp. 233-234

Authors: SCHILDER JM HURTEAU JA LOOK KY MOORE DH RAFF G STEHMAN FB SUTTON GP
Citation: Jm. Schilder et al., A PROSPECTIVE CONTROLLED TRIAL OF EARLY POSTOPERATIVE ORAL INTAKE FOLLOWING MAJOR ABDOMINAL GYNECOLOGIC SURGERY, Gynecologic oncology, 67(3), 1997, pp. 235-240

Authors: MONK BJ TEWARI K BURGER RA JOHNSON MT MONTZ FJ BERMAN ML
Citation: Bj. Monk et al., A COMPARISON OF INTRACAVITARY VERSUS INTERSTITIAL IRRADIATION IN THE TREATMENT OF CERVICAL-CANCER, Gynecologic oncology, 67(3), 1997, pp. 241-247

Authors: MCCONNELL DT MILLER ID PARKIN DE MURRAY GI
Citation: Dt. Mcconnell et al., P53 PROTEIN EXPRESSION IN A POPULATION-BASED SERIES OF PRIMARY VULVARSQUAMOUS-CELL CARCINOMA AND IMMEDIATE ADJACENT FIELD CHANGE, Gynecologic oncology, 67(3), 1997, pp. 248-254

Authors: LOOK KY BLESSING JA VALEA FA MCGEHEE R MANETTA A WEBSTER KD ANDERSEN WA
Citation: Ky. Look et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN IN RECURRENT ADENOCARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 67(3), 1997, pp. 255-258

Authors: JUWEID M SWAYNE LC SHARKEY RM DUNN R RUBIN AD HERSKOVIC T GOLDENBERG DM
Citation: M. Juweid et al., PROSPECTS OF RADIOIMMUNOTHERAPY IN EPITHELIAL OVARIAN-CANCER - RESULTS WITH IODINE-131-LABELED MURINE AND HUMANIZED MN-14 ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODIES, Gynecologic oncology, 67(3), 1997, pp. 259-271

Authors: MORGAN MA STADTMAUER EA LUGER SM PORTER DL MANGAN PA ONEIL P KAMELLE S BENJAMIN I MICK R KING SA RUBIN SC
Citation: Ma. Morgan et al., CYCLES OF DOSE-INTENSIVE CHEMOTHERAPY WITH PERIPHERAL STEM-CELL SUPPORT IN PERSISTENT OR RECURRENT PLATINUM-SENSITIVE OVARIAN-CANCER, Gynecologic oncology, 67(3), 1997, pp. 272-276

Authors: LUO MP GOMPERTS B IMREN S DECLERCK YA ITO M VELICESCU M FELIX JC DUBEAU L
Citation: Mp. Luo et al., ESTABLISHMENT OF LONG-TERM IN-VITRO CULTURES OF HUMAN OVARIAN CYSTADENOMAS AND LMP TUMORS AND EXAMINATION OF THEIR SPECTRUM OF EXPRESSION OF MATRIX-DEGRADING PROTEINASES, Gynecologic oncology, 67(3), 1997, pp. 277-284

Authors: KASHIMURA M SUGIHARA K TOKI N MATSUURA Y KAWAGOE T KAMURA T KAKU T TSURUCHI N NAKASHIMA H SAKAI H
Citation: M. Kashimura et al., THE SIGNIFICANCE OF PERITONEAL CYTOLOGY IN UTERINE CERVIX AND ENDOMETRIAL CANCER, Gynecologic oncology, 67(3), 1997, pp. 285-290

Authors: HELMKAMP F KREBS HB KILEY LA
Citation: F. Helmkamp et al., WITZEL GASTROSTOMY IN GYNECOLOGIC SURGERY, Gynecologic oncology, 67(3), 1997, pp. 291-294

Authors: KOUL A BORG A PEJOVIC T BENDAHL PO HOGBERG T IOSIF CS KILLANDER D
Citation: A. Koul et al., IDENTIFICATION OF TP53 GENE-MUTATIONS IN UTERINE CORPUS CANCER WITH SHORT FOLLOW-UP, Gynecologic oncology, 67(3), 1997, pp. 295-302

Authors: PIROG EC HELLER DS WESTHOFF C
Citation: Ec. Pirog et al., ENDOMETRIAL ADENOCARCINOMA - LACK OF CORRELATION BETWEEN TREATMENT DELAY AND TUMOR STAGE, Gynecologic oncology, 67(3), 1997, pp. 303-308

Authors: STOCK RG DOTTINO P JENNINGS TS TERK M DEWYNGAERT JK BEDDOE AM COHEN C
Citation: Rg. Stock et al., ENHANCED RADIOSENSITIZATION WITH INTERFERON-ALPHA-2B AND CISPLATIN INTHE TREATMENT OF LOCALLY ADVANCED CERVICAL-CARCINOMA, Gynecologic oncology, 67(3), 1997, pp. 309-315

Authors: NORDAL RR KRISTENSEN GB STENWIG AE NESLAND JM PETTERSEN EO TROPE CG
Citation: Rr. Nordal et al., AN EVALUATION OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA, Gynecologic oncology, 67(3), 1997, pp. 316-321

Authors: FARLEY JH TAYLOR RR
Citation: Jh. Farley et Rr. Taylor, CERVICAL CARCINOSARCOMA OCCURRING AFTER SUBTOTAL HYSTERECTOMY, A CASE-REPORT, Gynecologic oncology, 67(3), 1997, pp. 322-324

Authors: VERNOOIJ CB KRUITWAGEN RFPM RODRIGUS P KOCK HCLV FEYEN HWH
Citation: Cb. Vernooij et al., HEMATOMETRA AFTER RADIOTHERAPY FOR CERVICAL-CARCINOMA, Gynecologic oncology, 67(3), 1997, pp. 325-327

Authors: SCHORGE JO MOLPUS KL NIKRUI N GOODMAN A FULLER AF
Citation: Jo. Schorge et al., UNTITLED - REPLY, Gynecologic oncology, 67(3), 1997, pp. 328-329

Authors: MORRIS M EIFEL PJ
Citation: M. Morris et Pj. Eifel, UNTITLED, Gynecologic oncology, 67(3), 1997, pp. 328-328

Authors: OREILLY S ARMSTRONG DK GROCHOW LB
Citation: S. Oreilly et al., LIFE-THREATENING MYELOSUPPRESSION IN PATIENTS WITH OCCULT RENAL IMPAIRMENT RECEIVING TOPOTECAN, Gynecologic oncology, 67(3), 1997, pp. 329-330

Authors: MUTO MG
Citation: Mg. Muto, GENETIC PREDISPOSITION TESTING - TAKING THE LEAD, Gynecologic oncology, 67(2), 1997, pp. 121-122

Authors: BELLER U HALLE D CATANE R KAUFMAN B HORNREICH G LEVYLAHAD E
Citation: U. Beller et al., HIGH-FREQUENCY OF BRCA1 AND BRCA2 GERMLINE MUTATIONS IN ASHKENAZI JEWISH OVARIAN-CANCER PATIENTS, REGARDLESS OF FAMILY HISTORY, Gynecologic oncology, 67(2), 1997, pp. 123-126

Authors: AGHAJANIAN C BROWN C OFLAHERTY C FLEISCHAUER A CURTIN J VONROEMELING R SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-I STUDY OF TIRAPAZAMINE AND CISPLATIN IN PATIENTS WITH RECURRENT CERVICAL-CANCER, Gynecologic oncology, 67(2), 1997, pp. 127-130

Authors: CHEN MD PALEY PJ POTISH RA TWIGGS LB
Citation: Md. Chen et al., PHASE-I TRIAL OF TAXOL AS A RADIATION SENSITIZER WITH CISPLATIN IN ADVANCED CERVICAL-CANCER, Gynecologic oncology, 67(2), 1997, pp. 131-136

Authors: SEEWALDT VL CAIN JM GOFF BA TAMIMI H GREER B FIGGE D
Citation: Vl. Seewaldt et al., A RETROSPECTIVE REVIEW OF PACLITAXEL-ASSOCIATED GASTROINTESTINAL NECROSIS IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 67(2), 1997, pp. 137-140

Authors: PIVER MS ELTABBAKH GH HEMPLING RE RECIO FO BLUMENSON LE
Citation: Ms. Piver et al., 2 SEQUENTIAL STUDIES FOR PRIMARY PERITONEAL CARCINOMA - INDUCTION WITH WEEKLY CISPLATIN FOLLOWED BY EITHER CISPLATIN-DOXORUBICIN-CYCLOPHOSPHAMIDE OR PACLITAXEL-CISPLATIN, Gynecologic oncology, 67(2), 1997, pp. 141-146
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>